Prolira makers of DeltaScan®

About:

DeltaScan® Brain State Monitor is an EEG bedside device with a validated algorithm to support clinicians to optimize patient recovery.

Website: https://prolira.com/en/

Top Investors: Holland Capital, OostNL, Borski Fund, ROM Utrecht Region, Health Innovations

Description:

Prolira is committed to enabling early and effective treatment of acute encephalopathy and delirium. Every year, 20 million patients are at risk of acute brain failure in EU and US hospitals, which leads to long-term cognitive impairment, extended hospital stays, and increased healthcare costs. Prolira’s DeltaScan® Brain State Monitor is the world’s first EEG bedside device with a validated proprietary algorithm to support clinicians in their quest to optimize patient recovery.

Total Funding Amount:

6.8M EUR

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Utrecht, Utrecht, The Netherlands

Founded Date:

2015-01-01

Contact Email:

info(AT)prolira.com

Founders:

Annemarie Willems, Rutger van Merkerk

Number of Employees:

11-50

Last Funding Date:

2022-02-01

IPO Status:

Private

Industries:

© 2025 bioDAO.ai